A systematic review of gemcitabine and taxanes combination therapy randomized trials for metastatic breast cancer

PURPOSE: Gemcitabine/taxanes-based combination shows anti-tumor activity for the treatment of metastatic breast cancer, but there is a debate regarding the advantages of gemcitabine and taxanes regimens as a first-line or second-line treatment for metastatic breast cancer. Here we conducted a system...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Springerplus
Egile Nagusiak: Hu, Qian, Jiang, Jun-xia, Luo, Long, Yang, Xing, Lin, Xiao, Dinglin, Xiao-xiao, Zhang, Wei, Wu, Jun-yan, Yao, He-rui
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer International Publishing 2014
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4447724/
https://ncbi.nlm.nih.gov/pubmed/26034661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2193-1801-3-293
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak